Trusted Resources: Education
Scientific literature and patient education texts
Proposal of An Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS IA) Among Children With Growth Abnormalities
source: Medicina (Kaunas, Lithuania)
year: 2022
authors: Baronio F,Zucchini S,Zulian F,Salerno M,Parini R,Cattoni A,Deodato F,Gaeta A,Bizzarri C,Gasperini S,Pession A
summary/abstract:Diagnostic delay is common in attenuated Mucopolysaccharidosis Type I (MPS Ia) due to the rarity of the disease and the variability of clinical presentation. Short stature and impaired growth velocity are frequent findings in MPS Ia, but they rarely raise suspicion as paediatric endocrinologists are generally poorly trained to detect earlier and milder clinical signs of this condition. : Following a consensus-based methodology, a multidisciplinary panel including paediatric endocrinologists, paediatricians with expertise in metabolic disorders, radiologists, and rheumatologists shared their experience on a possible clinical approach to the diagnosis of MPS Ia in children with short stature or stunted growth. : The result was the formation of an algorithm that illustrates how to raise the suspicion of MPS Ia in a patient older than 5 years with short stature and suggestive clinical signs. : The proposed algorithm may represent a useful tool to improve the awareness of paediatric endocrinologists and reduce the diagnostic delay for patients with MPS Ia.
organization: Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.DOI: 10.3390/medicina58010097
read more
Related Content
-
Trigger Finger in Children With Hurler Syndrome – Distribution Pattern and Treatment OptionsMucopolysaccharidosis is a rare and cong...
-
Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsGene therapy might soon offer a new opti...
-
Hurler Syndrome Treatment Market Research Prophesied to Grow at a Faster Pace By 2026This Hurler Syndrome Treatment market re...
-
A Guide to Understanding MPS IMPS I is a mucopolysaccharide disease al...
-
EMA Grants Orphan Drug Designation to JR-171 for the Treatment of Mucopolysaccaridosis Type I (MPS I)JCR Pharmaceuticals Co., Ltd. announced ...
-
Stewart RustDr Rust completed his first degree at Le...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...